Loading
Life sciences · Journal article
Archives of Medical Reports · September 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Infectious diseases remains as one of the major public health concerns worldwide. The continuous emergence of new pathogens, rapid pathogen evolution, and environmental changes has increased the population mobility. Meanwhile, the antimicrobial resistance has made disease prevention and control more challenging. Conventional surveillance systems mainly depend on clinical reports and laboratory confirmation. These approaches often delay outbreak detection and public health response. Recent advances in big data analytics have improved the infectious disease surveillance by enabling the analysis of large health related datasets. Information collected from electronic health records, laboratory databases, pathogen genome sequencing, environmental monitoring, mobile health technologies, and digital platforms provides valuable insights into disease transmission and outbreak patterns. Artificial intelligence supports the analysis of these complex datasets and improve outbreak prediction. Precision public health further strengthens disease surveillance by integrating epidemiological, genomic, environmental, and social data. This approach helps to identify the high risk populations and supports targeted intervention strategies. Despite these advantages, several challenges include poor data quality, privacy concerns, algorithmic bias, limited interoperability, and unequal access to digital technologies. Addressing these limitations through standardized data management, ethical governance, and international collaboration will improve surveillance systems and strengthen preparedness against current and emerging infectious disease threats.